Neuroimaging in Patients Undergoing TMS for Depression
Completed · Not applicable
Conditions studied: Treatment Resistant Depression
In brief
The goal of this project is to guide rTMS using functional magnetic resonance imaging (fMRI) in individuals with depression who did not respond to standard TMS treatment to evaluate whether targeted TMS using individualized functional MRI scans produce outcome superior to that of conventional approaches. The study team also plans to scan patients with Major Depression Disorder (MDD) patients prescribed to receive standard TMS for the first time before and after which they will have resting-state Functional Magnetic Resonance Imaging (rs-FMRI) scan in order to see if we can predict their responsiveness based on the functional connectivity maps.
Key facts
- Study ID
- NCT02974296
- Run by
- New York State Psychiatric Institute
- People needed
- 33
- Starts
- 2017-04-30
- Expected to finish
- 2019-08-20
- Last updated by the study team
- 2020-10-23
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- New York State Psychiatric Institute — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.